Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response

Journal of Neuroscience Research

Volumn 87, Issue 7, 2009, Pages 1679-1685

  Köllensperger, Martin ^a   Stefanova, Nadia ^a   Pallua, Anton ^a   Puschban, Zoe ^a   Dechant, Georg ^a   Hainzer, Monika ^a   Reindl, Markus ^a   Poewe, Werner ^a   Nikkhah, Guido ^b   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Behavior; L Dopa response; MSA; Transplantation

Indexed keywords

APOMORPHINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; EMBRYO; EXPERIMENTAL TEST; LOCOMOTION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION; SHY DRAGER SYNDROME; STRIATONIGRAL DEGENERATION; TISSUE TRANSPLANTATION;

ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; LEVODOPA; MALE; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; RANDOM ALLOCATION; RATS; RATS, WISTAR; TRANSPLANTATION, HOMOLOGOUS;

EID: 65849406011     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21972     Document Type: Article

References (34)

1. Adams MR, Van Bogaert L, van der Eecken H. 1961. Nigro-striate and cerebello-nigro-striate degeneration [Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type]. Psychiatr Neurol 142:219-259.
2. Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. 1999. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Exp Brain Res Exp Hirnforschung 128:535-538.
3. Churchyard A, Donnan GA, Hughes A, Howells DW, Woodhouse D, Wong JY, Kalnins RM, Mendelsohn FA, Paxinos G. 1993. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors. Ann Neurol 34:219-226.
4. Correale J, Villa A. 2004. The neuroprotective role of inflammation in nervous system injuries. J Neurol 251:1304-1316.
5. Dobrossy MD, Dunnett SB. 2003. Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol 184:274-284.
6. Dobrossy MD, Dunnett SB. 2006. Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise. Eur J Neurosci 24:3223-3233.
7. Dobrossy MD, Dunnett SB. 2007. The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease. Behav Brain Res 179:326-330.
8. Fearnley JM, Lees AJ. 1990. Striatonigral degeneration. A clinicopathological study. Brain 113:1823-1842.
9. Fricker RA, Torres EM, Dunnett SB. 1997. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience 79:695-710.
10. Fricker-Gates RA, White A, Gates MA, Dunnett SB. 2004. Striatal neurons in striatal grafts are derived from both post-mitotic cells and dividing progenitors. Eur J Neurosci 19:513-520.
11. Goto S, Matsumoto S, Ushio Y, Hirano A. 1996. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology 47:1032-1036.
12. Hanna PA, Jankovic J, Kirkpatrick JB. 1999. Multiple system atrophy: the putative causative role of environmental toxins. Arch Neurol 56:90-94.
13. Kashihara K, Manabe Y, Shiro Y, Warita H, Abe K. 2000. Effects of repeated methyl levodopa administration on apomorphine sensitivity of rotational behavior and striatal Fos expression of rats with unilateral 6-OHDA lesions. Neurosci Res 38:273-279.
14. Köllensperger M, Stefanova N, Reindl M, Poewe W, Wenning GK. 2007. Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy. Mov Disord 22:353-358.
15. Nakao N, Brundin P. 1997. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 76:749-761.
16. Nakao N, Ogura M, Nakai K, Itakura T. 1999. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease. Neuroscience 88:469-477.
17. Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ. 1991. Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1:9-13.
18. Olsson M, Nikkhah G, Bentlage C, Bjorklund A. 1995. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. JNeurosci 15:3863-3875.
19. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK. 2000a. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience 95:377-388.
20. Puschban Z, Waldner R, Seppi K, Stefanova N, Humpel C, Scherfler C, Levivier M, Poewe W, Wenning GK. 2000b. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy). Exp Neurol 164:166-175.
21. Quinn NP, Marsden CD. 1993. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 56:1239-1242.
22. Rodter A, Winkler C, Samii M, Nikkhah G. 2000. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant 9:197-214.
23. Roedter A, Winkler C, Samii M, Walter GF, Brandis A, Nikkhah G. 2001. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J Comp Neurol 432:217-229.
24. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. 2000. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787.
25. Scherfler C, Puschban Z, Ghorayeb I, Goebel GP, Tison F, Jellinger K, Poewe W, Wenning GK. 2000. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 99:43-54.
26. St.-Hilaire M, Landry E, Levesque D, Rouillard C. 2005. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism. Neurobiol Dis 20:450-460.
27. Stefanova N, Lundblad M, Tison F, Poewe W, Cenci MA, Wenning GK. 2004. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). Neurobiol Dis 15:630-639.
28. Torres EM, Dowd E, Dunnett SB. 2008. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease. Neuroscience 154:631-640.
29. Trojanowski JQ, Revesz T. 2007. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615-620.
30. Watts C, Brasted PJ, Dunnett SB. 2000. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp Neurol 163:85-97.
31. Wenning GK, Granata R, Laboyrie PM, Quinn NP, Jenner P, Marsden CD. 1996. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Disord 11:522-532.
32. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. 1997. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133-147.
33. Wenning GK, Colosimo C, Geser F, Poewe W. 2004. Multiple system atrophy. Lancet Neurol 3:93-103.
34. Wenning GK, Geser F, Poewe W. 2005. Therapeutic strategies in multiple system atrophy. Mov Disord 20(Suppl 12):S67-S76.